当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2012年第21期 > 正文
编号:12252014
替米沙坦联合硝苯地平控释片对肥胖性高血压患者的疗效观察(3)
http://www.100md.com 2012年7月25日 吴池
第1页

    参见附件。

     [3] Madrigal L,Brady J,Raxter M,et al. Obesity,hypertension,and migration:a meta-analysis of populations of the South Asian diaspora [J]. Hum Biol,2011,83(1):71-86.

    [4] Galie N,Manes A,Negro L,et al. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension [J]. Eur Heart J,2009,30(4):394-403.

    [5] Derosa G,Maffioli P. Nifedipine and telmisartan for the treatment of hypertension:the TALENT study [J]. Expert Rev Cardiovasc Ther,2011,9(12):1499-1503.

    [6] Aalbers J. Improving hypertension control in patients at cardiovascular risk:the case for telmisartan-based therapy [J]. Cardiovasc J Afr,2011,22(1):45-46.

    [7] Marketou ME,Kontaraki JE,Tsakountakis NA,et al. Differential effect of telmisartan and amlodipine on monocyte chemoattractant protein-1 and peroxisome proliferator-activated receptor-gamma gene expression in peripheral monocytes in patients with essential hypertension [J]. Am J Cardiol,2011,107(1):59-63.

    [8] Schneider F,Vossler S,Franke S,et al. Impact of insulin sensitivity treatment with pioglitazone on endothelial function in non-diabetic patients with arterial hypertension [J]. Int J Clin Pharmacol Ther,2009,47(5):311-320.

    (收稿日期:2012-03-19 本文编辑:张瑜杰)

您现在查看是摘要介绍页,详见PDF附件(2032kb)